Dados B3 › JBSS3
JBSS3 (JBS): has profit grown?
JBSS3 (JBS): in 2025, net income attributable to controlling shareholders was R$ 11.4 billion, up 18% versus 2024 (a profit of R$ 9.6 billion); five years earlier (2020), a profit of R$ 4.6 billion.
| Year | Profit (loss) | Change |
|---|---|---|
| 2025 | R$ 11.4 billion | up 18% |
| 2024 | R$ 9.6 billion | a turn from loss to profit |
| 2023 | -R$ 1.1 billion | a turn from profit to loss |
| 2022 | R$ 15.5 billion | down 25% |
| 2021 | R$ 20.5 billion | up 346% |
| 2020 | R$ 4.6 billion | down 24% |
| 2019 | R$ 6.1 billion | up 23,982% |
| 2018 | R$ 25.2 million | down 95% |
| 2017 | R$ 534.2 million | up 42% |
| 2016 | R$ 376.0 million | — |
Annual statements (DFP). Profit attributable to controlling shareholders when the company reports it; otherwise total net income. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/JBSS3/fatos - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: JBSS3.
Dividends · Debt · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:13 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:13 UTC. If this does not match /saude, you are reading a cached copy.